Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.23) by 164.32 percent. This is a 27.66 percent decrease over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $104.478 million which missed the analyst consensus estimate of $107.310 million by 2.64 percent. This is a 24.30 percent increase over sales of $84.052 million the same period last year.